We are studying the safety and effectiveness of alectinib in children with solid or CNS tumors that have not responded to other treatments. This trial aims to find the best dose and understand how the drug works in young patients.
Health conditions and diseases that the clinical trial is designed to study and treat.
Malignant mast cell tumors are a type of cancer that arises from mast cells, which are involved in allergic reactions and immune responses. These tumors can occur in various parts of the body and may lead to serious health issues.
ALK fusion-positive tumors are a type of cancer characterized by a genetic alteration involving the ALK gene, often seen in certain solid tumors and can lead to aggressive disease progression.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
